Mar 16, 2022 / 05:35PM GMT
Carter Lewis Gould - Barclays Bank PLC, Research Division - Senior Analyst
Good afternoon, and welcome to the Barclays Global Healthcare Conference. My name is Carter Gould, senior biopharma analyst here at Barclays. Welcome. And next up is Bristol-Myers Squibb. We're really happy to have Bristol here, again, one of these companies that we've been looking forward to meet in person over the past 2 years. And joining from the company is the CMO and Head of Global Drug Development, Samit Hirawat. Samit, thank you very much for joining us today.
Samit Hirawat - Bristol-Myers Squibb Company - Executive VP & Chief Medical Officer of Global Drug Development
Thank you, Carter. Pleasure.
Questions and Answers:
Carter Lewis Gould - Barclays Bank PLC, Research Division - Senior AnalystAnd in contrast to many of your peers, you have a very active 2022 from a catalyst perspective. A lot of clinical data, a number of launches coming up, so no shortage of stuff to talk about today. And in fact, you had a very busy week
Trustpilot
